Emissary International

Emissary International is a contract research organization (CRO) that provides comprehensive clinical trial management services to the biotechnology and pharmaceutical sectors. The company specializes in Phase I-IV clinical monitoring, project management, and regulatory consulting, with a focus on delivering high-quality data for complex clinical programs. Founded in 1999 and headquartered in North Carolina's Research Triangle Park, Emissary established a reputation for personalized service and operational excellence. In 2013, the firm was acquired by SynteractHCR (now part of Syneos Health), integrating its expertise into a larger global clinical development platform. The acquisition allowed the combined entity to enhance its service offerings in key therapeutic areas such as oncology and infectious diseases.